CMS issues proposed decision memorandum for screening for cervical cancer with testing
Physician Practice Insider, May 5, 2015
On April 16, CMS posted a proposed decision memorandum stating evidence is sufficient to add Human Papillomavirus (HPV) testing once every five years as an additional preventive service benefit under the Medicare program for asymptomatic beneficiaries aged 30 to 65 years in conjunction with the pap smear test. CMS will cover screening for cervical cancer with the appropriate FDA-approved/cleared laboratory tests, used consistent with FDA-approved labeling and in compliance with the CLIA regulations.
View the proposed decision memorandum.
This article originally appeared in Medicare Weekly Insider.
Related Products
Most Popular
- Articles
-
- Don't forget the three checks in medication administration
- Note similarities and differences between HCPCS, CPT® codes
- CDC alert: Screen for international travel as Ebola cases increase
- Q&A: Primary, principal, and secondary diagnoses
- Differentiate between types of wound debridement
- Complications from immobility by body system
- Nursing responsibilities for managing pain
- Practice the six rights of medication administration
- OB services: Coding inside and outside of the package
- The consequences of an incomplete medical record
- E-mailed
-
- CDC alert: Screen for international travel as Ebola cases increase
- Capturing start and stop times for infusions
- Differentiate between types of wound debridement
- Performing a SWOT analysis
- Life Safety Code Q&A: Ambulatory care soiled utility room
- Leadership training for charge nurses
- Helping Charge Nurses understand their leadership role (Part 2 of 3)
- Five ways to safeguard your patients' valuables
- Developing a Fall-Prevention Program
- Coding, billing, and documentation tips for teaching physicians, interns, residents, and students
- Searched